Aspirin use and bleeding volume in skin cancer patients undergoing surgery: a randomized controlled trial

ᅟ: We investigated the occurrence of bleeding complications in patients who underwent skin tumor surgery and compared it between Aspirin users and a placebo control group. In this double blind randomized controlled trial, 32 patients who continued taking aspirin (intervention group) and 38 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Engheta, Arman, Hadadi Abianeh, Shahryar, Atri, Ali, Sanatkarfar, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964271/
https://www.ncbi.nlm.nih.gov/pubmed/27465859
http://dx.doi.org/10.1186/s40199-016-0159-4
_version_ 1782445073968922624
author Engheta, Arman
Hadadi Abianeh, Shahryar
Atri, Ali
Sanatkarfar, Mehdi
author_facet Engheta, Arman
Hadadi Abianeh, Shahryar
Atri, Ali
Sanatkarfar, Mehdi
author_sort Engheta, Arman
collection PubMed
description ᅟ: We investigated the occurrence of bleeding complications in patients who underwent skin tumor surgery and compared it between Aspirin users and a placebo control group. In this double blind randomized controlled trial, 32 patients who continued taking aspirin (intervention group) and 38 patients who stopped taking Aspirin (placebo group) before surgery were compared in terms of intraoprative and postoperative bleeding problems, hematoma and local signs of coagulopathy. There was no statistically significant difference in intraoprative bleeding between the study groups (P = 0.107). We concluded that continuation of Aspirin therapy had no significant effect on bleeding complications in patients who underwent skin tumor surgery. TRIAL REGISTRATION: IRCT201602049768N5 GRAPHICAL ABSTRACT: Flow chart of the study process and its final finding [Image: see text]
format Online
Article
Text
id pubmed-4964271
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49642712016-07-29 Aspirin use and bleeding volume in skin cancer patients undergoing surgery: a randomized controlled trial Engheta, Arman Hadadi Abianeh, Shahryar Atri, Ali Sanatkarfar, Mehdi Daru Letter to the Editor ᅟ: We investigated the occurrence of bleeding complications in patients who underwent skin tumor surgery and compared it between Aspirin users and a placebo control group. In this double blind randomized controlled trial, 32 patients who continued taking aspirin (intervention group) and 38 patients who stopped taking Aspirin (placebo group) before surgery were compared in terms of intraoprative and postoperative bleeding problems, hematoma and local signs of coagulopathy. There was no statistically significant difference in intraoprative bleeding between the study groups (P = 0.107). We concluded that continuation of Aspirin therapy had no significant effect on bleeding complications in patients who underwent skin tumor surgery. TRIAL REGISTRATION: IRCT201602049768N5 GRAPHICAL ABSTRACT: Flow chart of the study process and its final finding [Image: see text] BioMed Central 2016-07-28 /pmc/articles/PMC4964271/ /pubmed/27465859 http://dx.doi.org/10.1186/s40199-016-0159-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter to the Editor
Engheta, Arman
Hadadi Abianeh, Shahryar
Atri, Ali
Sanatkarfar, Mehdi
Aspirin use and bleeding volume in skin cancer patients undergoing surgery: a randomized controlled trial
title Aspirin use and bleeding volume in skin cancer patients undergoing surgery: a randomized controlled trial
title_full Aspirin use and bleeding volume in skin cancer patients undergoing surgery: a randomized controlled trial
title_fullStr Aspirin use and bleeding volume in skin cancer patients undergoing surgery: a randomized controlled trial
title_full_unstemmed Aspirin use and bleeding volume in skin cancer patients undergoing surgery: a randomized controlled trial
title_short Aspirin use and bleeding volume in skin cancer patients undergoing surgery: a randomized controlled trial
title_sort aspirin use and bleeding volume in skin cancer patients undergoing surgery: a randomized controlled trial
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964271/
https://www.ncbi.nlm.nih.gov/pubmed/27465859
http://dx.doi.org/10.1186/s40199-016-0159-4
work_keys_str_mv AT enghetaarman aspirinuseandbleedingvolumeinskincancerpatientsundergoingsurgeryarandomizedcontrolledtrial
AT hadadiabianehshahryar aspirinuseandbleedingvolumeinskincancerpatientsundergoingsurgeryarandomizedcontrolledtrial
AT atriali aspirinuseandbleedingvolumeinskincancerpatientsundergoingsurgeryarandomizedcontrolledtrial
AT sanatkarfarmehdi aspirinuseandbleedingvolumeinskincancerpatientsundergoingsurgeryarandomizedcontrolledtrial

Ejemplares similares